Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Viruses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01323244
What this trial is testing

TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

Who this might be right for
Hepatitis C
Janssen R&D Ireland 142
Testing effectiveness (Phase 2)Active Not RecruitingNCT06537414
What this trial is testing

Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B Virus InfectionHepatitis B
GlaxoSmithKline 283
Early research (Phase 1)Study completedNCT05017116
What this trial is testing

A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Chronic Hepatitis B
Suzhou Ribo Life Science Co. Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Large-scale testing (Phase 3)Study completedNCT02346721
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Not applicableLooking for participantsNCT07563309
What this trial is testing

Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV 1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 1,000
Post-approval studies (Phase 4)UnknownNCT05016609
What this trial is testing

Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)

Who this might be right for
Hepatitis C
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 1,800
Testing effectiveness (Phase 2)Study completedNCT06115993
What this trial is testing

Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients

Who this might be right for
Hepatitis B, Chronic
Ausper Biopharma Co., Ltd. 129
Not applicableEnded earlyNCT01886300
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 16
Testing effectiveness (Phase 2)Study completedNCT00226447
What this trial is testing

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 30
Early research (Phase 1)Study completedNCT04168333
What this trial is testing

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B Virus (HBV)
Tasly Tianjin Biopharmaceutical Co., Ltd. 36
Not applicableStudy completedNCT05621304
What this trial is testing

Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)

Who this might be right for
Chronic Hepatitis B Virus (Hbv)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 274
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Not applicableUnknownNCT01329952
What this trial is testing

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Who this might be right for
Hepatitis C
Pennine Acute Hospitals NHS Trust 90
Not applicableUnknownNCT06313255
What this trial is testing

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

Who this might be right for
Chronic Hepatitis B
Qilu Hospital of Shandong University 40
Testing effectiveness (Phase 2)Study completedNCT00255177
What this trial is testing

Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Who this might be right for
Hepatitis C Virus Infection
VGX Pharmaceuticals, LLC 44
Testing effectiveness (Phase 2)Study completedNCT02751996
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

Who this might be right for
Hepatitis BHepatitis, Viral
F-star Therapeutics, Inc. 80
Not applicableStudy completedNCT04139941
What this trial is testing

Evaluation Study of HCV RDTs in Fresh Samples

Who this might be right for
Hepatitis C Virus Infection
Foundation for Innovative New Diagnostics, Switzerland 1,540
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797231
What this trial is testing

Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 930
Next Page